DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 312 participants.

Also called NCT07241897

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 312 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07241897
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07241897. Randomized; triple masking; primary purpose treatment. Start 2025-12-15 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes
Condition
Diabete Mellitus
Intervention (Drug)
Sentagliptin Phosphate - single dose
Intervention (Drug)
Placebo
Lead sponsor
Second Affiliated Hospital of Soochow University (class: other)

Record details

Record id
cardio:ct-nct07241897
Content hash
46b4a49c9735f8bb2a282e75ebe30f2a4d2523a035db163e11c8f8e9cf7516c8